Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Therapeutic Drug Monitoring for Rheumatoid Arthritis
Recruiting1 award
Boston, Massachusetts
This trial is testing whether a proactive, individualized approach to therapy optimization, based on serum drug levels and the presence or absence of anti-drug antibodies, results in a higher rate of achieving and/or maintaining therapeutic goal compared to standard of care in patients with RA.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.